Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors

J Clin Endocrinol Metab. 2001 Mar;86(3):1355-61. doi: 10.1210/jcem.86.3.7332.

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome with multiple tumors of the endocrine pancreas, the parathyroid, the pituitary, and other tissues. The MEN1 gene at 11q13 is homozygously mutated in the majority of MEN1 tumors. Here we present a genome-wide loss of heterozygosity (LOH) screening of 23 pancreatic lesions, one duodenal tumor, and one thymic carcinoid from 13 MEN1 patients. Multiple allelic deletions were found. Fractional allelic loss varied from 6-75%, mean 31%. All pancreatic tumors displayed LOH on chromosome 11, whereas the frequency of losses for chromosomes 3, 6, 8, 10, 18, and 21 was over 30%. Different lesions from individual patients had discrepant patterns of LOH. Intratumoral heterogeneity was revealed, with chromosome 6 and 11 deletions in most tumor cells, whereas other chromosomal loci were deleted in portions of the analyzed tumor. Chromosome 6 deletions were mainly found in lesions from patients with malignant features. Fractional allelic loss did not correlate to malignancy or to tumor size. Our findings indicate that MEN1 pancreatic tumors fail to maintain DNA integrity and demonstrate signs of chromosomal instability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alleles*
  • Carcinoid Tumor / genetics
  • Chromosomes, Human, Pair 11
  • Chromosomes, Human, Pair 6
  • Duodenal Neoplasms / genetics
  • Gene Deletion*
  • Genetic Markers
  • Humans
  • Loss of Heterozygosity*
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 1 / genetics*
  • Pancreatic Neoplasms / genetics*
  • Pancreatic Neoplasms / pathology
  • Thymus Neoplasms / genetics

Substances

  • Genetic Markers